Analyst Price Targets — APA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 2, 2026 10:29 am | Noah Hungness | Wells Fargo | $50.00 | $44.30 | TheFly | APA Corp. assumed with an Equal Weight at Wells Fargo |
| September 2, 2026 8:58 am | John Freeman | Raymond James | $54.00 | $44.30 | StreetInsider | APA Corp. (APA) PT Raised to $54 at Raymond James |
| August 19, 2026 11:23 am | Bill Selesky | Argus Research | $48.00 | $42.37 | StreetInsider | Argus Upgrades APA Corp. (APA) to Buy |
| August 13, 2026 1:07 am | — | Wells Fargo | $49.00 | $39.97 | TheFly | APA Corp. price target raised to $49 from $39 at Wells Fargo |
| August 12, 2026 12:05 pm | — | KeyBanc | $46.00 | $40.08 | StreetInsider | APA Corp. (APA) PT Raised to $46 at Benchmark as Net Debt Declines |
| August 11, 2026 11:29 am | — | Susquehanna | $47.00 | $41.02 | TheFly | APA Corp. price target raised to $47 from $45 at Susquehanna |
| August 6, 2026 4:16 pm | Leo Mariani | Roth Capital | $39.00 | $36.04 | TheFly | APA Corp. posts 'mixed' Q2 results, says Roth Capital |
| July 21, 2026 12:25 pm | — | Susquehanna | $45.00 | $35.26 | TheFly | APA Corp. price target lowered to $45 from $47 at Susquehanna |
| July 15, 2026 11:58 am | — | UBS | $41.00 | $33.96 | TheFly | APA Corp. price target lowered to $41 from $45 at UBS |
| July 13, 2026 12:51 pm | — | Raymond James | $50.00 | $34.47 | TheFly | APA Corp. price target lowered to $50 from $57 at Raymond James |
Latest News for APA
E deepens its Uruguay offshore push with exploration deals for OFF-5 and OFF-6 blocks, while backing a planned 2027 well in OFF-6.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
U.S. Patent 12,679,817, covering novel processes for preparing the (R)- and (S)-enantiomers of MDMA and MBDB, granted to PharmAla by the US Patent and Trademark Office (USPTO) PharmAla has exercised its option to cancel the proposed licensing of APA-01 to Restora Neurosciences, and will evaluate in-house and co-development pathways Canaccord Genuity LLC has been engaged as exclusive financial advisor and placement…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.